{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T11:42:11Z","timestamp":1794138131030,"version":"4.8.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005984","name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005984","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017192","name":"University of Southern California Norris Comprehensive Cancer Center","doi-asserted-by":"publisher","award":["P30CA014089"],"award-info":[{"award-number":["P30CA014089"]}],"id":[{"id":"10.13039\/100017192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025154","name":"University of Sadat City","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025154","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA258013"],"award-info":[{"award-number":["U01CA258013"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.neo.2025.101189","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T23:23:32Z","timestamp":1749165812000},"page":"101189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Single-cell proteomic analysis reveals Multiple Myeloma heterogeneity and the dynamics of the tumor immune microenvironment in precursor and advanced states"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8663-8846","authenticated-orcid":false,"given":"Mohamed","family":"Kamal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie N.","family":"Shishido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5933-5003","authenticated-orcid":false,"given":"Jeremy","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krina","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet E.","family":"Manasanch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Z.","family":"Orlowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2629-4505","authenticated-orcid":false,"given":"Peter","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neo.2025.101189_bib0001","first-page":"3","article-title":"Multiple myeloma: a clinical overview","volume":"25","author":"Anderson","year":"2011","journal-title":"Oncology"},{"issue":"1","key":"10.1016\/j.neo.2025.101189_bib0002","doi-asserted-by":"crossref","first-page":"58","DOI":"10.7861\/clinmedicine.19-1-58","article-title":"Haematology: multiple myeloma","volume":"19","author":"Firth","year":"2019","journal-title":"Clin. Med."},{"issue":"9","key":"10.1016\/j.neo.2025.101189_bib0003","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/jamaoncol.2018.2128","article-title":"Global burden of multiple myeloma: a systematic analysis for the global burden of disease study 2016","volume":"4","author":"Cowan","year":"2018","journal-title":"JAMA Oncol."},{"issue":"6","key":"10.1016\/j.neo.2025.101189_bib0004","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/leu.2010.60","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management","volume":"24","author":"Kyle","year":"2010","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.neo.2025.101189_bib0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.seminhematol.2010.11.003","article-title":"Pathogenesis of monoclonal gammopathy of undetermined significance and progression to multiple myeloma","volume":"48","author":"Zingone","year":"2011","journal-title":"Semin. Hematol."},{"issue":"18","key":"10.1016\/j.neo.2025.101189_bib0006","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1056\/NEJMoa2409029","article-title":"Daratumumab or active monitoring for high-risk smoldering multiple myeloma","volume":"392","author":"Dimopoulos","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.neo.2025.101189_bib0007","first-page":"17","article-title":"Multiple myeloma insights from single-cell analysis: clonal evolution, the microenvironment, therapy evasion, and clinical implications","author":"Li","year":"2025","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.neo.2025.101189_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13020217","article-title":"The role of tumor microenvironment in multiple myeloma development and progression","volume":"13","author":"Garc\u00eda-Ortiz","year":"2021","journal-title":"Cancers"},{"issue":"22","key":"10.1016\/j.neo.2025.101189_bib0009","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1182\/bloodadvances.2022007217","article-title":"Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level","volume":"6","author":"Schinke","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.neo.2025.101189_bib0010","series-title":"Proteomics","first-page":"55","article-title":"Chapter 3 - proteomics: application of next-generation proteomics in cancer research","author":"Mir","year":"2023"},{"issue":"12","key":"10.1016\/j.neo.2025.101189_bib0011","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.molcel.2022.05.022","article-title":"Unbiased spatial proteomics with single-cell resolution in tissues","volume":"82","author":"Mund","year":"2022","journal-title":"Mol. Cell"},{"issue":"12","key":"10.1016\/j.neo.2025.101189_bib0012","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1038\/s41590-023-01678-9","article-title":"Decoding the tumor microenvironment with spatial technologies","volume":"24","author":"Walsh","year":"2023","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.neo.2025.101189_bib0013","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1158\/1078-0432.CCR-16-1355","article-title":"Paired high-content analysis of prostate cancer cells in bone marrow and blood characterizes increased androgen receptor expression in tumor cell clusters","volume":"23","author":"Carlsson","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.neo.2025.101189_bib0014","doi-asserted-by":"crossref","DOI":"10.1088\/1478-3975\/9\/1\/016003","article-title":"Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers","volume":"9","author":"Marrinucci","year":"2012","journal-title":"Phys. Biol."},{"issue":"21","key":"10.1016\/j.neo.2025.101189_bib0015","first-page":"23","article-title":"Characterization of bcma expression in circulating rare single cells of patients with plasma cell neoplasms","author":"Ndacayisaba","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neo.2025.101189_bib0016","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41698-023-00446-0","article-title":"Targeted single-cell proteomic analysis identifies new liquid biopsy biomarkers associated with multiple myeloma","volume":"7","author":"Setayesh","year":"2023","journal-title":"NPJ Precis. Oncol."},{"issue":"22","key":"10.1016\/j.neo.2025.101189_bib0017","first-page":"16","article-title":"Multi-omic characterization of single cells and cell-free components detected in the cerebrospinal fluid of patients with leptomeningeal disease","author":"Shishido","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.neo.2025.101189_bib0018","doi-asserted-by":"crossref","unstructured":"Welter, L., et al., Cell state and cell type: deconvoluting circulating tumor cell populations in liquid biopsies by multi-omics. Cancers, 2023. 15(15).","DOI":"10.3390\/cancers15153949"},{"issue":"12","key":"10.1016\/j.neo.2025.101189_bib0019","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/s41591-018-0269-2","article-title":"Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma","volume":"24","author":"Ledergor","year":"2018","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.neo.2025.101189_bib0020","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41419-024-07027-4","article-title":"Single-cell sequencing analysis of multiple myeloma heterogeneity and identification of new theranostic targets","volume":"15","author":"Wang","year":"2024","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.neo.2025.101189_bib0021","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/s43018-024-00784-3","article-title":"The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities","volume":"5","author":"Ramberger","year":"2024","journal-title":"Nature Cancer"},{"issue":"8","key":"10.1016\/j.neo.2025.101189_bib0022","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/sj.leu.2403823","article-title":"CD45 expression by bone marrow plasma cells in multiple myeloma: clinical and biological correlations","volume":"19","author":"Kumar","year":"2005","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.neo.2025.101189_bib0023","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41408-024-01172-x","article-title":"Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages","volume":"14","author":"Cheng","year":"2024","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.neo.2025.101189_bib0024","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1038\/s41467-021-22804-x","article-title":"Co-evolution of tumor and immune cells during progression of multiple myeloma","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.neo.2025.101189_bib0025","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1158\/2326-6066.CIR-22-0434","article-title":"Immune phenotypes and target antigens of clonally expanded bone marrow t cells in treatment-na\u00efve multiple myeloma","volume":"10","author":"Welters","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.neo.2025.101189_bib0026","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1158\/2159-8290.CD-22-0482","article-title":"MinimuMM-seq: genome sequencing of circulating tumor cells for minimally invasive molecular characterization of multiple myeloma pathology","author":"Dutta","year":"2023","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.neo.2025.101189_bib0027","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.1182\/blood-2024-203100","article-title":"Single-cell multi-omics analysis reveals heterogeneity of malignant plasma cell during progression of multiple myeloma","volume":"144","author":"Feng","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.neo.2025.101189_bib0028","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/s41591-018-0269-2","article-title":"Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma","volume":"24","author":"Ledergor","year":"2018","journal-title":"Nat. Med."}],"updated-by":[{"DOI":"10.1016\/j.neo.2025.101226","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000}}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625000685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625000685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T19:27:22Z","timestamp":1757532442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558625000685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":28,"alternative-id":["S1476558625000685"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2025.101189","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-cell proteomic analysis reveals Multiple Myeloma heterogeneity and the dynamics of the tumor immune microenvironment in precursor and advanced states","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2025.101189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101189"}}